Transient neonatal diabetes mellitus
Log in to starLast updated Nov 3, 2026
A newborn with severe IUGR develops hyperglycemia in the first week of life requiring insulin. Diabetes resolves by 12 weeks but recurs in adolescence.
Most cases are an imprinting disorder: overexpression of the paternally expressed genes PLAGL1 and HYMAI at 6q24. A smaller share is AD, from activating variants in KCNJ11 or ABCC8, which encode the Kir6.2 and SUR1 subunits of the beta-cell KATP channel.
- 6q24 abnormalities (paternal UPD6, paternal duplication, or loss of maternal methylation): ~70% of TNDM
- KCNJ11, ABCC8 variants: usually a cause of permanent neonatal diabetes; those with milder effects on the channel cause TNDM
At 6q24, the maternal copies of PLAGL1 and HYMAI are silenced by methylation and only the paternal copies are expressed. Each 6q24 mechanism leaves an extra expressed copy, so PLAGL1 is overexpressed:
- Paternal UPD6 (about 41% of 6q24 cases): two paternal copies. Most UPD6 is isodisomic, which can unmask recessive disorders such as HFE-related hemochromatosis.
- Paternal 6q24 duplication (about 29%): de novo or inherited from the father; if he carries it, each sib has a 50% risk.
- Loss of maternal methylation (about 30%): isolated, or part of a multilocus imprinting disturbance, most often from biallelic ZFP57 variants. Congenital anomalies are more frequent with UPD6 or a multilocus disturbance.
PLAGL1 encodes a zinc finger protein. How its overexpression causes diabetes is not fully understood, but affected infants have a defect of glucose-stimulated insulin secretion, and low insulin in utero is assumed to explain the growth restriction. Methylation analysis detects all three mechanisms, so it establishes the diagnosis but not the mechanism.
Activating KCNJ11 and ABCC8 variants keep the KATP channel from closing, so glucose does not trigger insulin release.
- Onset first week of life
- IUGR
- Resolves by 3-18 months (usually)
- Risk of recurrence (especially puberty/pregnancy)
- Hyperglycemia requiring treatment in the first weeks of life, typically with IUGR; distinguish from permanent neonatal diabetes by later resolution
- Methylation/genetic testing of the 6q24 imprinted locus (paternal UPD6, paternal duplication, or maternal hypomethylation) accounts for most cases
- Test KCNJ11 and ABCC8 (K-ATP channel) variants, especially if diabetes persists or to guide therapy
- Insulin during the active hyperglycemic phase, titrated as endogenous control returns; manage IUGR/feeding
- For KCNJ11/ABCC8 (K-ATP channel) cases, sulfonylureas can replace insulin
- Long-term follow-up for recurrence of diabetes (commonly in adolescence or during pregnancy)
- Genetic counseling tailored to mechanism (UPD6, paternal duplication, K-ATP channel variants have distinct recurrence implications)